新型 Src 激酶抑制剂对 APP/PS1 小鼠的神经保护作用

罗蕊 ,  张芯玮 ,  刘洋 ,  王磊 ,  吴小君 ,  肖军海 ,  林凤

高等学校化学学报 ›› 2026, Vol. 47 ›› Issue (11) : 62 -71.

PDF (12156KB)
高等学校化学学报 ›› 2026, Vol. 47 ›› Issue (11) : 62 -71. DOI: 10.7503/cjcu20260242
研究论文

新型 Src 激酶抑制剂对 APP/PS1 小鼠的神经保护作用

作者信息 +

Neuroprotective Effects of Novel Src Kinase Inhibitor on APP/PS1 Mice

Author information +
文章历史 +
PDF (12446K)

摘要

研究了Src酪氨酸蛋白激酶抑制剂Y-11对转基因小鼠APP/PS1的神经保护作用. 结果表明, Y-11的给药可以显著改善阿尔茨海默病(AD)小鼠的认知功能障碍, 降低大脑中AD病理相关蛋白的表达. 同时, Y-11通过抑制胶质细胞激活, 增加突触蛋白水平, 减轻神经炎症并缓解突触功能的障碍. 以上研究表明, Y-11具有对AD的神经保护作用, 为Src抑制剂治疗AD提供了理论基础.

Abstract

This study was designed to explore the neuroprotective potential of Y-11, a Src tyrosine kinase inhibitor, in transgenic APP/PS1 mice. Administration of Y-11 to these mice resulted in a marked amelioration of cognitive deficits characteristic of Alzheimer’s disease(AD), along with a reduction in the expression levels of AD-related pathological proteins within the brain. Meanwhile, Y-11also attenuated neuroinflammation and synaptic dysfunction by inhibiting glial cell activation, and restored synaptic protein levels. In summary, the results suggested that Y-11 had neuroprotective effects on AD mice, provided a theoretical basis on the potential therapeutic application of Src kinase inhibitors in Alzheimer’s disease.

关键词

Src激酶抑制剂 / 阿尔茨海默病 / 1,3-硒唑-5-甲酰胺衍生物

Key words

Src kinase inhibitor / Alzheimer’s disease(AD) / 1,3-Selenazole-5-formamide derivate

引用本文

引用格式 ▾
罗蕊,张芯玮,刘洋,王磊,吴小君,肖军海,林凤. 新型 Src 激酶抑制剂对 APP/PS1 小鼠的神经保护作用[J]. 高等学校化学学报, 2026, 47(11): 62-71 DOI:10.7503/cjcu20260242

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Rostagno A. A., Int. J. Mol. Sci., 2022, 24(1), 107

[2]

Baviskar P. S., Mahajan H. S., Ageing Research Reviews, 2026, 114, 102990

[3]

Cai Y., Liu J., Wang B., Sun M., Yang H., Front. Immunol., 2022, 13, 856376

[4]

Briggs R., Kennelly S. P., O'neill D., Clin. Med. (Lond), 2016, 16(3), 247-253

[5]

Manning G., Whyte D. B., Martinez R., Hunter T., Sudarsanam S., Science, 2002, 298(5600), 1912-1934

[6]

Hubbard S. R., Till J. H., Annu. Rev. Biochem., 2000, 69, 373-398

[7]

Nygaard H. B., Biol. Psychiatry, 2018, 83(4), 369-376

[8]

Dhawan G., Floden A. M., Combs C. K., Neurobiol. Aging, 2012, 33(10), 2247-2261

[9]

Socodato R., Portugal C. C., Domith I., Oliveira N. A., Coreixas V. S., Loiola E. C., Martins T., Santiago A. R., Paes-De-Carvalho R., Ambrósio A. F., Relvas J. B., Glia, 2015, 63(3), 497-511

[10]

Hennequin L. F., Allen J., Breed J., Curwen J., Fennell M., Green T. P., Lambert-Van Der Brempt C., Morgentin R., Norman R. A., Olivier A., Otterbein L., Plé P. A., Warin N., Costello G., J. Med. Chem., 2006, 49(22), 6465-6488

[11]

Chiu L. Y., Hsin I. L., Tsai J. N., Chen C. J., Ou C. C., Wu W. J., Sheu G. T., Ko J. L., J. Cell Physiol., 2021, 236(2), 1148-1157

[12]

Ramos R., Vale N., Int. J. Mol. Sci., 2024, 25(8), 4565

[13]

Nygaard H. B., Wagner A. F., Bowen G. S., Good S. P., Macavoy M. G., Strittmatter K. A., Kaufman A. C., Rosenberg B. J., Sekine-Konno T., Varma P., Chen K., Koleske A. J., Reiman E. M., Strittmatter S. M., Van Dyck C. H., Alzheimers Res. Ther., 2015, 7(1), 35

[14]

Wu P., Nielsen T. E., Clausen M. H., Trends Pharmacol. Sci., 2015, 36(7), 422-439

[15]

Tang S. J., Fesharaki-Zadeh A., Takahashi H., Nies S. H., Smith L. M., Luo A., Chyung A., Chiasseu M., Strittmatter S. M., Acta Neuropathol. Commun., 2020, 8(1), 96

[16]

Kaufman A. C., Salazar S. V., Haas L. T., Yang J., Kostylev M. A., Jeng A. T., Robinson S. A., Gunther E. C., Van Dyck C. H., Nygaard H. B., Strittmatter S. M., Ann. Neurol., 2015, 77(6), 953-971

[17]

Wang H., Yue Y., Zhao H., Wu H., Jiang K., Li S., Zhao M., Lin F., Neurotox Res., 2021, 39(3), 841-850

[18]

Wang H. Y., Study on the Inhibitory Effects of Src Inhibitor on Aβ Toxicity in AD C. elegans and its Mechanism, Jilin University, Changchun, 2019

[19]

(王慧莹. Src抑制剂对AD线虫Aβ毒性的抑制作用及其机制研究, 长春: 吉林大学, 2019)

[20]

Yu H. X., The design, Synthesis and Screening on Overriding Resistance of Bcr-Abl Selectivity Inhibitors, Guangxi University, Nanning, 2006

[21]

(于海侠. 抗耐药作用的Bcr-Abl选择性抑制剂的设计、 合成与筛选, 南宁: 广西大学, 2006)

[22]

Kong F., Jiang X., Wang R., Zhai S., Zhang Y., Wang D., J. Neuroinflammation, 2020, 17(1), 305

[23]

Guo X., Wen S., Wang J., Zeng X., Yu H., Chen Y., Zhu X., Xu L., Phytomedicine, 2024, 130, 155705

[24]

Duyvestyn J. M., Taylor S. J., Dagger S. A., Langdon W. Y., Exp. Hematol., 2016, 44(5), 410-421

[25]

Lagas J. S., Van Waterschoot R. A., Van Tilburg V. A., Hillebrand M. J., Lankheet N., Rosing H., Beijnen J. H., Schinkel A. H., Clin. Cancer Res., 2009, 15(7), 2344-2351

[26]

Vorhees C. V., Williams M. T., Nat. Protoc., 2006, 1(2), 848-858

[27]

Prieur E. A. K., Jadavji N. M., Bio. Protoc., 2019, 9(3), e3162

[28]

Golden R. K., Dilger R. N., Front. Behav. Neurosci., 2024, 18, 1434489

[29]

Bierman E. J., Comijs H. C., Jonker C., Beekman A. T., Dement. Geriatr. Cogn. Disord., 2007, 24(3), 213-219

[30]

Kosel F., Pelley J. M. S., Franklin T. B., Neurosci. Biobehav. Rev., 2020, 112, 634-647

[31]

Pentkowski N. S., Rogge-Obando K. K., Donaldson T. N., Bouquin S. J., Clark B. J., Neurosci. Biobehav. Rev., 2021, 127, 647-658

[32]

Liu D. Z., Neural. Regen. Res., 2017, 12(6), 910-911

[33]

Zheng Q., Wang X., Protein & Cell, 2025, 16(2), 83-120

[34]

Meur S., Karati D., Mol. Neurobiol., 2025, 62(1), 643-660

[35]

Um J. W., Nygaard H. B., Heiss J. K., Kostylev M. A., Stagi M., Vortmeyer A., Wisniewski T., Gunther E. C., Strittmatter S. M., Nat. Neurosci., 2012, 15(9), 1227-1235

[36]

Iannuzzi F., Sirabella R., Canu N., Maier T. J., Annunziato L., Matrone C., Cells, 2020, 9(8), 1807

[37]

Lee G., Thangavel R., Sharma V. M., Litersky J. M., Bhaskar K., Fang S. M., Do L. H., Andreadis A., Van Hoesen G., Ksiezak-Reding H., J. Neurosci., 2004, 24(9), 2304-2312

[38]

Brier M. R., Gordon B., Friedrichsen K., Mccarthy J., Stern A., Christensen J., Owen C., Aldea P., Su Y., Hassenstab J., Cairns N. J., Holtzman D. M., Fagan A. M., Morris J. C., Benzinger T. L., Ances B. M., Sci. Transl. Med., 2016, 8(338), 338ra366

[39]

Zhang P., Kishimoto Y., Grammatikakis I., Gottimukkala K., Cutler R. G., Zhang S., Abdelmohsen K., Bohr V. A., Misra Sen J., Gorospe M., Mattson M. P., Nat. Neurosci., 2019, 22(5), 719-728

[40]

Gurbani D., Du G., Henning N. J., Rao S., Bera A. K., Zhang T., Gray N. S., Westover K. D., Front. Mol. Biosci., 2020, 7, 81

[41]

Dhawan G., Combs C. K., J. Neuroinflammation, 2012, 9, 117

[42]

Bai Y. W., Yang Q. H., Chen P. J., Wang X. Q., Front. Immunol., 2023, 14, 1172293

[43]

Park M. N., Kim H. W., Hong J. H., Kim J. K., Lee S. B., Baek H. S., Kwak S., Kwon Y. J., Park K., Jeon J., Heo N. H., Lee S. H., Cho J., Kim S., Int. J. Mol. Sci., 2026, 27(11), 4720

[44]

Rajani V., Sengar A. S., Salter M. W., Neuropharmacology, 2021, 193, 108615

[45]

Escamilla S., Badillos R., Comella J. X., Solé M., Pérez-Otaño I., Mut J. V. S., Sáez-Valero J., Cuchillo-Ibáñez I., Alzheimer's & Dementia, 2024, 20(12), 8231-8245

[46]

Liu Y., Zhang Y., Zheng X., Fang T., Yang X., Luo X., Guo A., Newell K. A., Huang X. F., Yu Y., J. Neuroinflammation, 2018, 15(1), 112

基金资助

吉林省科技厅自然科学基金会(20220101268JC)

AI Summary AI Mindmap
PDF (12156KB)

5

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉